Přejít k obsahu
Merck

Hlavní dokumenty

Zobrazit celou dokumentaci

Přeskočit na

04-1645

Rabbit Anti-Mouse IgG2a kappa light chain Antibody, clone RM107

Přihlásit pro zobrazení organizačních a smluvních cen.

Vybrat velikost

Změnit zobrazení
Velikost baleníSkladová položkaDostupnostCena
100 μg

Očekávané datum odeslání17. dubna 2026odAreál Kühne+Nagel spol. s r.o.

8 410,00 Kč

O této položce

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
RM107, monoclonal
Species reactivity:
mouse, rabbit
Application:
ELISA, WB
Citations:
-

8 410,00 Kč

Očekávané datum odeslání17. dubna 2026podrobné informace

​
Požádejte o hromadnou objednávku
Technický servis
Potřebujete pomoc? Náš tým zkušených odborníků je vám k dispozici.
Dovolte nám, abychom vám pomohli

antibody form

purified antibody

Quality Level

300

clone

RM107, monoclonal

purified by

using Protein A

species reactivity

mouse, rabbit

concentration

(Please refer to lot specific datasheet.)

technique(s)

ELISA: suitable, western blot: suitable

isotype

IgG

General description

Mouse IgG

Application

Western Blotting Analysis (WB): 0.2 μg/mL from a representative lot detected Mouse IgG2a kappa light chain in nonreduced mouse IgG2aκ.

Biochem/physiol Actions

This antibody reacts to the Fab region of mouse IgG2aκ. No cross reactivity with mouse IgG2aγ, IgG1, IgG3, IgM, IgA, IgE, human IgG, rat IgG, or goat IgG. The Fc region of RM107 has been engineered to eliminate the binding of Fc receptor.

Physical form

Rabbit monoclonal in PBS with 1% BSA and 0.09% sodium azide.

Preparation Note

Stable for 1 year at 2-8°C from date of receipt.Note: Variability in freezer temperatures below -20°C may cause glycerol containing solutions to become frozen during storage.

Analysis Note

ELISA Analysis: The specificity and reactivity of a representative lot was confirmed by ELISA analyses.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Skladovací třída

12 - Non Combustible Liquids

wgk

WGK 2

flash_point_f

Not applicable

flash_point_c

Not applicable

Osvědčení o analýze (COA)

Vyhledejte osvědčení Osvědčení o analýze (COA) zadáním čísla šarže/dávky těchto produktů. Čísla šarže a dávky lze nalézt na štítku produktu za slovy „Lot“ nebo „Batch“.

Již tento produkt vlastníte?

Dokumenty související s produkty, které jste v minulosti zakoupili, byly za účelem usnadnění shromážděny ve vaší Knihovně dokumentů.

Navštívit knihovnu dokumentů

Související obsah

Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System

A major focus of breast cancer research is to understand the mechanisms responsible for disease progression and drug resistance. Toward that end, it has been found that approximately two thirds of all human breast carcinomas overexpress the Estrogen Receptor α (ERα) protein and it remains the primary pharmacological target for endocrine therapy1,2. The normal cellular function of ERα is as a transcription factor that mediates a wide variety of physiological processes, many of which are dependent upon phosphorylation of the receptor at specific amino acid residues3,4. Indeed, ERα is known to be phosphorylated at a multitude of different sites, yet how these all correlate to disease remains unclear5. Here, we interrogated multiple sites of ERα for phosphorylation status by screening an extensive panel of different breast cancer patient samples and other non-breast cancer tissue microarray (TMA) slide samples to determine their relevance to disease.